Connect with us
A recent study conducted in France by Stratégies and Leyton shows that 88% of the French people are happy that a vaccine against COVID-19 was found....
BioNTech CEO Sierk Pötting expects to be able to present the first data from the ongoing study on the efficacy of BNT162 at the end of...
Bavaria has been able to establish itself as a location for biotechnology and innovation in recent decades. However, at an international level, still lags behind. One...
In the fight against the coronavirus pandemic, the Tübingen-based biotech company Curevac intends to start mass phase III tests before the end of the year. The...
The company operates under the name of Moderna Biotech Spain and its corporate purpose is the "development, manufacture and distribution of drugs, vaccines and medicines based...
The group of projects that are in the most advanced stage of testing to find the coronavirus vaccine is joined by the vaccine developed by the...
Next week, Panama will start human trials of a COVID-19 vaccine developed by a German biotech company. An impressive number of 4,000 volunteers have signed to...
The first healthy volunteer received, in the Roman hospital, the vaccine designed by the biotech company Reithera of Castel Romano. The company was funded with $9.46...
Moderna agreed to sell its coronavirus drug at a "pandemic price" of $32-37 per dose.The biotech company registered losses of $240 million in the first half...
The clinical trial, led by the Catholic University, together with other universities and the Sinovac Biotech laboratory, already has funding from the public sector, the Confederation...
